Investment Banking

Merger and Acquisition

We support our clients to achieve excellence by providing trusted strategic advice, capital raising and risk management services with a global perspective, and professional insights into the Chinese market in respect of the specific sectors. The service encompasses two areas: sell-side advice and merger transactions.

Biotech License-in/out

We are a leading advisor on licensing deals from early-stage to late-stage novel products for significant unmet medical needs. We bring value to our clients making license-in and out deals involving early and late development stage products, approved products and platform technologies specific to the biotech sector.
Based on our extensive expertise, we advise clients on a variety of complex transactions and novel deal structures, including:
-   global strategic alliances, joint ventures and collaborations;
-   business development and licensing support for both out-license and in-license assets depending upon the requirements;
-   co-development, co-commercialization, co-promotion and marketing agreements;
-   commercial and technical due diligence; asset valuation and positioning, target screening;
-   deal structuring, comparable analysis, term sheet analysis and negotiation, deal closure.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us